Prévisions du marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale jusqu’en 2030 – Analyse régionale – par classe de médicaments (antiviraux, antibactériens, antifongiques et autres), indication (VIH, hépatite, tuberculose, grippe, VPH et autres) , voie d\'administration (orale, parentérale, topique et autres) et canal de distribution (pharmacies hospitalières, pharmacies de détail et autres)

BMIRE00030547 | Pages: 90 | Pharmaceuticals | Jul 2024 | Type: Regional | Status: Published
Le marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale était évalué à 6 252,96 millions de dollars américains en 2022 et devrait atteindre 8 167,05 millions de dollars américains d’ici 2030 ; on estime qu\'il enregistrera un TCAC de 3,4 % de 2022 à 2030.

Les opportunités croissantes dans les pays en développement alimentent le marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale

L\'incidence croissante des maladies infectieuses devrait accroître les ventes de médicaments thérapeutiques contre les maladies infectieuses dans les pays en développement. En outre, les investissements élevés dans la recherche en santé et les sciences de la vie dans les pays émergents jouent un rôle clé dans la promotion des dernières technologies dans les pays en développement, ce qui, à son tour, soutient la tendance au diagnostic et au traitement des maladies infectieuses. Par exemple, l’ONUSIDA appelle à un investissement de 29 milliards de dollars d’ici 2025 pour répondre aux besoins des pays à revenu faible et intermédiaire en matière de riposte au sida. Ainsi, les fabricants cruciaux de produits thérapeutiques contre les maladies infectieuses sur les marchés émergents des thérapies contre les maladies infectieuses au Brésil devraient être témoins d’opportunités lucratives à l’avenir. Cela est dû à la forte prévalence de maladies infectieuses telles que l\'hépatite, les IAS, le VIH et la grippe ; une large population de patients ; une augmentation du revenu disponible de la population ; améliorer les infrastructures de soins de santé ; et le tourisme médical croissant dans ces pays.

Aperçu du marché thérapeutique des maladies infectieuses en Amérique du Sud et centrale

Le marché thérapeutique des maladies infectieuses en Amérique du Sud et centrale est sous-segmenté entre le Brésil, l\'Argentine et le reste de l\'Amérique du Sud et centrale. Le marché des traitements contre les maladies infectieuses en Amérique du Sud et en Amérique centrale devrait croître en raison de la prévalence accrue des maladies infectieuses, de l’essor des activités de recherche et de l’augmentation des dépenses de santé dans les pays de la région. Le Brésil a réalisé d\'énormes progrès dans le secteur de la santé grâce à l\'augmentation des dépenses de santé. Selon l\'Administration du commerce international, le Brésil consacre environ 9,1 % de son PIB aux soins de santé et constitue le principal marché de soins de santé en Amérique latine. On estime que le marché des traitements contre les maladies infectieuses au Brésil est en plein essor en raison de la prévalence croissante des maladies infectieuses.

Les maladies infectieuses restent une cause importante de décès au Brésil. Une enquête a révélé qu\'une forte charge de maladies infectieuses était observée chez les hommes et les enfants de moins de 5 ans, principalement en raison du VIH/SIDA. Selon les données fournies par le Programme commun des Nations Unies sur le VIH/SIDA (ONUSIDA), en 2022, environ 990 000 personnes vivaient avec le VIH et le SIDA au Brésil. Ainsi, en raison des facteurs mentionnés ci-dessus, le marché des produits thérapeutiques contre les maladies infectieuses au Brésil devrait croître au cours de la période de prévision.

Chiffre d\'affaires et prévisions du marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale jusqu\'en 2030 (en millions de dollars américains)

Segmentation du marché thérapeutique des maladies infectieuses en Amérique du Sud et centrale

Amérique du Sud et centrale Le marché des produits thérapeutiques contre les maladies infectieuses est classé en classe de médicaments, indication, voie d’administration, canal de distribution et pays.

En fonction de la classe de médicaments, le marché thérapeutique des maladies infectieuses d\'Amérique du Sud et d\'Amérique centrale est segmenté en antiviraux, antibactériens, antifongiques et autres. Le segment des antiviraux détenait la plus grande part de marché en 2022.

En termes d\'indication, le marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale est segmenté en VIH, hépatite, tuberculose, grippe, VPH et autres. Le VIH détenait la plus grande part de marché en 2022.

En fonction de la voie d\'administration, le marché thérapeutique des maladies infectieuses d\'Amérique du Sud et d\'Amérique centrale est segmenté en administration orale, parentérale, topique et autres. Le segment oral détenait la plus grande part de marché en 2022.

En termes de canal de distribution, le marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale est segmenté en pharmacies hospitalières, pharmacies de détail et autres. Les pharmacies hospitalières détenaient la plus grande part de marché en 2022.

Par pays, le marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale est segmenté entre le Brésil, l\'Argentine et le reste de l\'Amérique du Sud et centrale. Le Brésil a dominé la part de marché des produits thérapeutiques contre les maladies infectieuses en Amérique du Sud et en Amérique centrale en 2022.

AbbVie Inc, Astellas Pharma Inc, Bayer AG, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GSK Plc, Merck & Co Inc , et Pfizer Inc font partie des principales sociétés opérant sur le marché thérapeutique des maladies infectieuses en Amérique du Sud et en Amérique centrale.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Infectious Disease Therapeutics Market - Key Market Dynamics

4.1 South & Central America Infectious Disease Therapeutics Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Rising Prevalence of Infectious Disease

4.2.2 Increasing Focus on Funding and R&D in Infectious Disease Therapeutics

4.3 Market Restraints

4.3.1 Emergence of Anti-infective Drugs Resistance and Associated Side Effects

4.4 Market Opportunities

4.4.1 Growing Opportunities in Developing Nations

4.5 Future Trends

4.5.1 Rising Number of Product Approvals and Launches

4.6 Impact of Drivers and Restraints:

5. Infectious Disease Therapeutics Market - South & Central America Market Analysis

5.1 South & Central America Infectious Disease Therapeutics Market Revenue (US$ Million), 2022-2030

6. South & Central America Infectious Disease Therapeutics Market Analysis - by Drug Class

6.1 Overview

6.2 Anti-Viral

6.2.1 Overview

6.2.2 Anti-viral: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Anti-bacterial

6.3.1 Overview

6.3.2 Anti-bacterial: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Anti-fungal

6.4.1 Overview

6.4.2 Anti-fungal: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Others

6.5.1 Overview

6.5.2 Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Infectious Disease Therapeutics Market Analysis - by Indication

7.1 Overview

7.2 HIV

7.2.1 Overview

7.2.2 HIV: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Tuberculosis

7.4.1 Overview

7.4.2 Tuberculosis: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Influenza

7.5.1 Overview

7.5.2 Influenza: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.6 HPV

7.6.1 Overview

7.6.2 HPV: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Infectious Disease Therapeutics Market Analysis - by Route of Administration

8.1 Overview

8.2 Oral

8.2.1 Overview

8.2.2 Oral: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Parenteral

8.3.1 Overview

8.3.2 Parenteral: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Topical

8.4.1 Overview

8.4.2 Topical: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Infectious Disease Therapeutics Market Analysis - by Distribution Channel

9.1 Overview

9.2 Hospital Pharmacies

9.2.1 Overview

9.2.2 Hospital Pharmacies: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Retail Pharmacies

9.3.1 Overview

9.3.2 Retail Pharmacies: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Infectious Disease Therapeutics Market - Country Analysis

10.1 South & Central America Infectious Disease Therapeutics Market

10.1.1 South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast Analysis - by Country

10.1.1.1 South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 Brazil: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Brazil: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.2.2 Brazil: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.2.3 Brazil: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.2.4 Brazil: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

10.1.1.3 Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.4 Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Argentina: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.4.2 Argentina: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.4.3 Argentina: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.4.4 Argentina: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

10.1.1.5 Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.6 Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of South & Central America: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.6.2 Rest of South & Central America: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.6.3 Rest of South & Central America: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.6.4 Rest of South & Central America: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

11. Infectious Disease Therapeutics Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Infectious Disease Therapeutics Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Pfizer Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Gilead Sciences Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 F. Hoffmann-La Roche Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bayer AG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 GSK Plc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 AbbVie Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Merck & Co Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Astellas Pharma Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

List of Tables

Table 1. South & Central America Infectious Disease Therapeutics Market Segmentation

Table 2. South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Drug Class

Table 3. South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Indication

Table 4. South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 5. South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 6. South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Country

Table 7. Brazil: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 8. Brazil: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Indication

Table 9. Brazil: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 10. Brazil: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 11. Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 12. Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Indication

Table 13. Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 14. Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 15. Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 16. Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Indication

Table 17. Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 18. Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 19. Recent Inorganic Growth Strategies in the Infectious Disease Therapeutics Market

Table 20. Recent Organic Growth Strategies in the Infectious Disease Therapeutics Market

List of Figures

Figure 1. South & Central America Infectious Disease Therapeutics Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. South & Central America Infectious Disease Therapeutics Market Revenue (US$ Million), 2022-2030

Figure 4. South & Central America Infectious Disease Therapeutics Market Share (%) - by Drug Class (2022 and 2030)

Figure 5. Anti-viral: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Anti-bacterial: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Anti-fungal: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. South & Central America Infectious Disease Therapeutics Market Share (%) - by Indication (2022 and 2030)

Figure 10. HIV: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Hepatitis: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Tuberculosis: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Influenza: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. HPV: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. South & Central America Infectious Disease Therapeutics Market Share (%) - by Route Of Administration (2022 and 2030)

Figure 17. Oral: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Parenteral: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Topical: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. South & Central America Infectious Disease Therapeutics Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 22. Hospital Pharmacies: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Retail Pharmacies: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: South & Central America Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. South & Central America Infectious Disease Therapeutics Market, By Key Country - Revenue (2022) (US$ Million)

Figure 26. South & Central America Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. Brazil: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Argentina: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Rest of South & Central America: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Growth Strategies in the Infectious Disease Therapeutics Market

1. AbbVie Inc
2. Astellas Pharma Inc
3. Bayer AG
4. F. Hoffmann-La Roche Ltd
5. Gilead Sciences Inc
6. GSK Plc 
7. Merck & Co Inc 
8. Pfizer Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America infectious disease therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America infectious disease therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America infectious disease therapeutics market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440